HeartFlow, Inc. reported significant financial developments in its latest 10-Q filing for the quarter ending September 30, 2025. The company generated revenue of $46.3 million for the third quarter, marking a 41% increase from $32.9 million in the same period last year. For the nine months ending September 30, 2025, revenue reached $126.9 million, up 40% from $90.8 million in the prior year. Despite this growth, HeartFlow recorded a net loss of $50.9 million for the quarter, compared to a loss of $19.1 million in the previous year, and a net loss of $92.4 million for the nine-month period, up from $63.5 million.
The company’s operational metrics indicate a substantial increase in revenue case volume, which rose by 48% year-over-year. This growth was partially offset by a reduction in average sales price due to a higher proportion of revenue cases from clinic and office-based accounts, which typically have lower reimbursement rates. HeartFlow's gross margin improved slightly to 77% for the third quarter, up from 76% a year earlier, attributed to increased revenue case volume and enhanced production team productivity.
Strategically, HeartFlow completed its initial public offering (IPO) on August 11, 2025, raising approximately $332.3 million in net proceeds. This capital infusion allowed the company to repay $55 million of its 2024 Term Loan and fully extinguish the remaining balance of $60.1 million. The IPO also resulted in the conversion of $98.3 million in 2025 Convertible Notes into common stock, further strengthening the company's balance sheet. As of September 30, 2025, HeartFlow reported $291.2 million in cash and cash equivalents, a significant increase from $51.4 million at the end of 2024.
Operationally, HeartFlow has expanded its customer base, with over 1,100 accounts utilizing its HeartFlow Platform, which includes the HeartFlow FFRCT Analysis and the recently introduced HeartFlow Plaque Analysis. The company has also initiated limited market education efforts for the Plaque Analysis, which is currently covered by several payors. However, the company faces challenges in achieving widespread adoption of its products, particularly in light of ongoing regulatory scrutiny and the competitive landscape.
Looking ahead, HeartFlow anticipates continued investment in research and development to enhance its product offerings and expand its market presence. The company expects to incur additional losses as it scales operations and navigates the complexities of being a public entity. Despite these challenges, HeartFlow remains optimistic about its growth trajectory, driven by the increasing adoption of its AI-powered diagnostic solutions in the healthcare market.
About Heartflow, Inc.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.